Medication info
Evicasa 20 mg (Memantine Hydrochloride)

Evicasa 20 mg (Memantine Hydrochloride)

Prescription medicationTablet경구
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
한국룬드벡(주)
Appearance
Pink oval film-coated tablet imprinted with "20" on one side and "MEM" on the other side.
Packaging
28 tablets/box [14 tablets/PTP x 2]
Approval status
Active

MFDS item code 202107380 · Approved 2021.11.10 · Insurance code 668000160

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medication is administered orally once daily and should be given at the same time every day. If necessary, it can be given twice a day. Dosage increase: The maximum daily dose is 20 mg, with an increase of 5 mg weekly over the first 3 weeks. - First week: 5 mg once daily - Second week: 10 mg once daily - Third week: 15 mg once daily - From the fourth week: 20 mg once daily Maintenance dose: 20 mg once daily Elderly patients.

Ingredients

Importer
한국룬드벡(주)

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for patients with moderate to severe Alzheimer's disease. Alzheimer's disease is characterized by memory loss and cognitive impairment, and this medication helps to alleviate symptoms and improve the patient's ability to carry out daily activities. It supports the patient in maintaining a more stable condition by slowing the progression of symptoms.

How to take

Adult dose

This medication is administered orally once daily and should be given at the same time every day. If necessary, it can be given twice a day. Dosage increase: The maximum daily dose is 20 mg, with an increase of 5 mg weekly over the first 3 weeks. - First week: 5 mg once daily - Second week: 10 mg once daily - Third week: 15 mg once daily - From the fourth week: 20 mg once daily Maintenance dose: 20 mg once daily Elderly patients.

Precautions

This medication should not be used in patients with known allergic reactions to any of its components. It should also not be administered to patients with severe liver impairment or severe renal impairment. Special caution is needed in patients with epilepsy or those with a history of seizures. Co-administration with other medications that have similar effects may increase the severity of side effects, so such combinations should be avoided. Significant changes in urine acidity may affect the excretion of this medication, requiring medical supervision. Patients with uncontrolled heart disease or hypertension should consult with a healthcare provider before using this medication. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and elevated blood pressure may occur, so physical condition should be closely monitored. Neurological side effects such as mental confusion or hallucinations can occur rarely, and any unusual symptoms should be reported to a healthcare provider immediately. There is potential for interactions with other medications, so it is essential to inform your healthcare provider of any other medications you are currently taking. Women who are pregnant or may become pregnant should consult with a healthcare provider before taking this medication, and breastfeeding women are advised to discontinue breastfeeding. The safety and efficacy of this medication have not been established in children and adolescents under 18 years, so it is advisable to avoid use. In case of overdose, severe symptoms such as coma, seizures, and hallucinations may occur, so it is crucial to adhere to the prescribed dosage and visit a hospital immediately in case of overdose. This medication may affect the patient's reaction time, so caution is needed when driving or operating machinery. Store this medication out of the reach of children and do not transfer it to other containers.

Side effects and when to seek care immediately

Serious side effects

  • Seizures
  • psychotic reactions
  • hallucinations
  • confusion
  • heart failure
  • venous thrombosis/thromboembolism
  • hypertension
  • dyspnea
  • pancreatitis
  • hepatitis.

Mild side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • confusion
  • hallucinations
  • psychotic reactions
  • balance disorders
  • gait abnormalities
Show 10 more
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • increased liver function test values
  • hepatitis
  • fatigue
  • increased serum creatine phosphokinase.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from exposure to air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will ensure the safety of the medication's efficacy.

Appearance and packaging

Appearance

Pink oval film-coated tablet imprinted with "20" on one side and "MEM" on the other side.

Package unit

28 tablets/box [14 tablets/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.